172 related articles for article (PubMed ID: 37173287)
1. Neuromuscular retraining therapy combined with preceding botulinum toxin A injection for chronic facial paralysis.
Jeong J; Lee JM; Kim J
Acta Otolaryngol; 2023 May; 143(5):446-451. PubMed ID: 37173287
[TBL] [Abstract][Full Text] [Related]
2. An objective assessment of botulinum toxin type A injection in the treatment of post-facial palsy synkinesis and hyperkinesis using the synkinesis assessment questionnaire.
Neville C; Venables V; Aslet M; Nduka C; Kannan R
J Plast Reconstr Aesthet Surg; 2017 Nov; 70(11):1624-1628. PubMed ID: 28688864
[TBL] [Abstract][Full Text] [Related]
3. Botulinum Toxin in Facial Reanimation: Map of the Facial Musculature and Dosage.
VandeWater T; Hetzler L
Atlas Oral Maxillofac Surg Clin North Am; 2023 Mar; 31(1):71-83. PubMed ID: 36754509
[TBL] [Abstract][Full Text] [Related]
4. Evaluation and treatment of synkinesis with botulinum toxin following facial nerve palsy.
Toffola ED; Furini F; Redaelli C; Prestifilippo E; Bejor M
Disabil Rehabil; 2010; 32(17):1414-8. PubMed ID: 20156046
[TBL] [Abstract][Full Text] [Related]
5. Mirror biofeedback rehabilitation after administration of single-dose botulinum toxin for treatment of facial synkinesis.
Azuma T; Nakamura K; Takahashi M; Ohyama S; Toda N; Iwasaki H; Kalubi B; Takeda N
Otolaryngol Head Neck Surg; 2012 Jan; 146(1):40-5. PubMed ID: 21965443
[TBL] [Abstract][Full Text] [Related]
6. Botulinum toxin injection of both sides of the face to treat post-paralytic facial synkinesis.
Choi KH; Rho SH; Lee JM; Jeon JH; Park SY; Kim J
J Plast Reconstr Aesthet Surg; 2013 Aug; 66(8):1058-63. PubMed ID: 23683725
[TBL] [Abstract][Full Text] [Related]
7. Epidemiologic Overview of Synkinesis in 353 Patients with Longstanding Facial Paralysis under Treatment with Botulinum Toxin for 11 Years.
Salles AG; da Costa EF; Ferreira MC; do Nascimento Remigio AF; Moraes LB; Gemperli R
Plast Reconstr Surg; 2015 Dec; 136(6):1289-1298. PubMed ID: 26595022
[TBL] [Abstract][Full Text] [Related]
8. Outcomes of Buccinator Treatment With Botulinum Toxin in Facial Synkinesis.
Patel PN; Owen SR; Norton CP; Emerson BT; Bronaugh AB; Ries WR; Stephan SJ
JAMA Facial Plast Surg; 2018 May; 20(3):196-201. PubMed ID: 28973100
[TBL] [Abstract][Full Text] [Related]
9. Quantitative measurement of evolution of postparetic ocular synkinesis treated with botulinum toxin type A.
Cecini M; Pavese C; Comelli M; Carlisi E; Sala V; Bejor M; Toffola ED
Plast Reconstr Surg; 2013 Nov; 132(5):1255-1264. PubMed ID: 24165606
[TBL] [Abstract][Full Text] [Related]
10. Combined protocol for treatment of secondary effects from facial nerve palsy.
Monini S; De Carlo A; Biagini M; Buffoni A; Volpini L; Lazzarino AI; Barbara M
Acta Otolaryngol; 2011 Aug; 131(8):882-6. PubMed ID: 21534714
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic strategies in post-facial paralysis synkinesis in adult patients.
Terzis JK; Karypidis D
Plast Reconstr Surg; 2012 Jun; 129(6):925e-939e. PubMed ID: 22634691
[TBL] [Abstract][Full Text] [Related]
12. Neuromuscular Retraining versus BTX-A Injection in Subjects with Chronic Facial Nerve Palsy, A Clinical Trial.
Pourmomeny AA; Pourali E; Chitsaz A
Iran J Otorhinolaryngol; 2021 May; 33(116):151-155. PubMed ID: 34222106
[TBL] [Abstract][Full Text] [Related]
13. Platysma synkinesis in facial palsy and botulinum toxin type A.
Dall'Angelo A; Mandrini S; Sala V; Pavese C; Carlisi E; Comelli M; Toffola ED
Laryngoscope; 2014 Nov; 124(11):2513-7. PubMed ID: 24764160
[TBL] [Abstract][Full Text] [Related]
14. Management of synkinesis.
Husseman J; Mehta RP
Facial Plast Surg; 2008 May; 24(2):242-9. PubMed ID: 18470836
[TBL] [Abstract][Full Text] [Related]
15. Long-Term Changes in the Treatment Pattern of Botulinum Toxin A Injections for Postfacial Paralysis Synkinesis Following Modified Selective Neurectomy.
Hjelm N; Crippen M; Azizzadeh B
Facial Plast Surg Aesthet Med; 2021; 23(3):234-235. PubMed ID: 33306003
[No Abstract] [Full Text] [Related]
16. Botulinum toxin A treatment in facial palsy synkinesis: a systematic review and meta-analysis.
de Jongh FW; Schaeffers AWMA; Kooreman ZE; Ingels KJAO; van Heerbeek N; Beurskens C; Monstrey SJ; Pouwels S
Eur Arch Otorhinolaryngol; 2023 Apr; 280(4):1581-1592. PubMed ID: 36544062
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic strategies in post-facial paralysis synkinesis in pediatric patients.
Terzis JK; Karypidis D
J Plast Reconstr Aesthet Surg; 2012 Aug; 65(8):1009-18. PubMed ID: 22483723
[TBL] [Abstract][Full Text] [Related]
18. Treating Buccinator With Botulinum Toxin in Patients With Facial Synkinesis: A Previously Overlooked Target.
Wei LA; Diels J; Lucarelli MJ
Ophthalmic Plast Reconstr Surg; 2016; 32(2):138-41. PubMed ID: 26325382
[TBL] [Abstract][Full Text] [Related]
19. Re: "Treating Buccinator with Botulinum Toxin in Patients with Facial Synkinesis: A Previously Overlooked Target".
Chundury RV; Perry JD
Ophthalmic Plast Reconstr Surg; 2016; 32(1):70. PubMed ID: 26735958
[No Abstract] [Full Text] [Related]
20. Reply re: "Treating Buccinator with Botulinum Toxin in Patients with Facial Synkinesis: A Previously Overlooked Target".
Lucarelli MJ; Wei LA; Diels J
Ophthalmic Plast Reconstr Surg; 2016; 32(1):70-1. PubMed ID: 26735959
[No Abstract] [Full Text] [Related]
[Next] [New Search]
